CN102000233A - Oral traditional Chinese medicine for knife wounds - Google Patents
Oral traditional Chinese medicine for knife wounds Download PDFInfo
- Publication number
- CN102000233A CN102000233A CN2010105318648A CN201010531864A CN102000233A CN 102000233 A CN102000233 A CN 102000233A CN 2010105318648 A CN2010105318648 A CN 2010105318648A CN 201010531864 A CN201010531864 A CN 201010531864A CN 102000233 A CN102000233 A CN 102000233A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- radix
- treatment
- promoting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 34
- 208000027418 Wounds and injury Diseases 0.000 title claims abstract description 12
- 206010052428 Wound Diseases 0.000 title abstract 3
- 208000014674 injury Diseases 0.000 claims abstract description 18
- 241000431990 Drynaria sinica Species 0.000 claims abstract description 12
- 239000004863 Frankincense Substances 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 3
- 229940056582 human hair preparation Drugs 0.000 claims description 13
- 241000717739 Boswellia sacra Species 0.000 claims description 11
- 241000628997 Flos Species 0.000 claims description 11
- 241001057584 Myrrha Species 0.000 claims description 11
- 230000006378 damage Effects 0.000 claims description 10
- 239000009286 sanguis draxonis Substances 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 2
- 230000037308 hair color Effects 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 206010017076 Fracture Diseases 0.000 abstract description 27
- 208000002193 Pain Diseases 0.000 abstract description 20
- 230000036407 pain Effects 0.000 abstract description 20
- 210000004369 blood Anatomy 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 16
- 230000001737 promoting effect Effects 0.000 abstract description 14
- 230000008736 traumatic injury Effects 0.000 abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 210000000988 bone and bone Anatomy 0.000 abstract description 8
- 230000002175 menstrual effect Effects 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 2
- 230000003902 lesion Effects 0.000 abstract 3
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 241000131329 Carabidae Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 abstract 1
- 229910052683 pyrite Inorganic materials 0.000 abstract 1
- 239000011028 pyrite Substances 0.000 abstract 1
- 230000017423 tissue regeneration Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
- 208000010392 Bone Fractures Diseases 0.000 description 22
- 210000002435 tendon Anatomy 0.000 description 6
- 208000034656 Contusions Diseases 0.000 description 5
- 208000034526 bruise Diseases 0.000 description 5
- 230000006735 deficit Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000003414 extremity Anatomy 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010009346 Clonus Diseases 0.000 description 2
- 208000024779 Comminuted Fractures Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 210000003423 ankle Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000005021 gait Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 206010071050 Ankle deformity Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000007356 Fracture Dislocation Diseases 0.000 description 1
- 206010053206 Fracture displacement Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000002658 Intra-Articular Fractures Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010023204 Joint dislocation Diseases 0.000 description 1
- 241001347978 Major minor Species 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010061363 Skeletal injury Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000459 calcaneus Anatomy 0.000 description 1
- -1 calcic Substances 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an oral traditional Chinese medicine preparation for fractures, traumatic injury, various knife wounds and internal lesions caused by overexertion. The oral traditional Chinese medicine powder is prepared from frankincense, myrrh, safflower, rhubarb, himalayan teasel root, draconis sanguis, pyrite, ground beetle, angelica, drynaria baronii and carbonized hair. The oral traditional Chinese medicine is a natural medicine, has obvious effects on promoting blood circulation to stop pain, removing blood stasis, restoring menstrual flow, promoting reunion of fractured bones, promoting wound healing, promoting tissue regeneration and the like, and is mainly used for treating fractures, traumatic injury, various knife wounds, internal lesions caused by overexertion and the like. The traditional Chinese medicine does not have special smell, and is suitable for both adults and children; the traditional Chinese medicine has high curative effect, has obvious effect on alleviating pain, and can take effect after being taken for 40 minutes at the soonest, and the patient does not feel painful or can feel relieved pain; the traditional Chinese medicine has a course of treatment, with 30 days for a course of treatment, common patients can recover within one course of treatment, and serious patients can recover within 2-3 courses of treatment; and the treatment statistics on patients with fractures, traumatic injury and various internal lesions caused by overexertion indicate that the effective rate is up to 100%, the curative ratio is up to 98%, and the traditional Chinese medicine does not have any toxic or side effect.
Description
Technical field
The present invention relates to a kind of fracture, traumatic injury patient uses medicine, especially for the oral Chinese medicine preparation of fracture, traumatic injury, various red injury, impairment caused by overstrain.
Background technology
In the bone injury field, adopting traditional method usually is operative treatment, folder steel plate, to fracture dislocation forced resetting, fixes with Gypsum Fibrosum and gauze at present, and it is slow knitting often to occur, and causes fracture to close on joint osteoporosis decalcification, produces adverse consequences.The traditional Chinese medical science on fractures, with union of fracture be divided into early, in, back three periods, in treatment, be the Therapeutic Principle in three periods with blood circulation promoting and blood stasis dispelling, reunion of bone, liver and kidney tonifying respectively; But the traditional Chinese medical science particularly has limitation at serious intra-articular fracture and the extremity fracture of treatment aspect the fracture of ligament, blood vessel, nerve injury, the course of treatment is long, and curative effect is undesirable, the side effect in addition that has.
Summary of the invention
The object of the invention provide a kind of short treating period, curative effect height, nontoxic, have no side effect the red injury oral Chinese medicine of treatment fracture, traumatic injury, various red injury, impairment caused by overstrain.
Amount of drug of the present invention be the inventor according to secret prescription handed down in the family from generation to generation, draw through groping for many years to put into practice simultaneously, each amounts of components is for all having better curative effect in the following weight parts scope.This Chinese medicine is to be made by following Chinese medicine raw materials by weight proportion:
Olibanum 15～30g, Myrrha 15～30g, Flos Carthami 20～40g, Radix Et Rhizoma Rhei 10～25g, Radix Dipsaci 15～30g, Sanguis Draxonis 15～30g, Pyritum 20～35g, eupolyphage sece steleophaga 15～30, drynaria baronii 30～45g, Radix Angelicae Sinensis 30～50g, Crinis Carbonisatus 10～20g;
The carbide that described Crinis Carbonisatus becomes for the between twenty and fifty hair color roasting of not having hair dyed;
Each component of above-mentioned dosage is crushed to 60～80 orders makes powder or other dosage form.
Chinese medicine of the present invention selects for use following materials of weight proportions component to make:
Olibanum 25～30g, Myrrha 25～30, Flos Carthami 30～40g, Radix Et Rhizoma Rhei 20～25g, Radix Dipsaci 25～30g, Sanguis Draxonis 25～30g, Pyritum 25～35g, eupolyphage sece steleophaga 25～30g, drynaria baronii 30～45g, Radix Angelicae Sinensis 35～45g, Crinis Carbonisatus 15～20g.
Preferred ingredients dosage of the present invention is:
Olibanum 30g, Myrrha 30g, Flos Carthami 40g, Radix Et Rhizoma Rhei 25g, Radix Dipsaci 30g, Sanguis Draxonis 30g, Pyritum 35g, eupolyphage sece steleophaga 30g, drynaria baronii 45g, Radix Angelicae Sinensis 50g, Crinis Carbonisatus 20g.
Olibanum in the said components: all pains of blood stasis trusted subordinate, the arthralgia pain clonic spasm of the muscle, ulcer sore pain, traumatic injury, skin infection festers; Radix Angelicae Sinensis: enrich blood, promoting the circulation of blood, the merit that nourishes blood; Drynaria baronii: the kidney invigorating analgesia, blood circulation-invigorating tendon-strengthening, invigorating the liver and kidney, reuniting the fractured tendons and bones, promoting blood circulation and stopping pain; Myrrha: ulcer sore pain, trusted subordinate, all pains of muscles and bones, traumatic blood stasis, but external expelling pus and promoting granulation; Radix Et Rhizoma Rhei: purging heat and dredging bowels, the clots absorbing removing mass, yellow cellulitis, edema, blood stasis gathers, the external application detumescence of relieving inflammation or internal heat, carbuncle sore tumefacting virus; Radix Dipsaci, Flos Carthami: promoting blood circulation to restore menstrual flow, blood stasis removing pain relieving; The Radix Dipsaci invigorating the liver and kidney, reuniting the fractured tendons and bones, invigorate blood circulation, promoting the circulation of blood detumescence, granulation promoting pain relieving, strong waist knee joint; Pyritum: the blood and relieving pain that looses promotes union of fracture, reunion of fractured tendons and bones; Eupolyphage sece steleophaga: have effects such as relaxing muscles and tendons to promote blood circulation, blood stasis removing stimulate the menstrual flow, reducing swelling and alleviating pain; Crinis Carbonisatus: contain carbon element, cystine and lipid, various trace elements such as calcic, sodium, potassium, copper, ferrum, manganese in the ash can shorten and clotting time and blood plasma recalcification time.The present invention invigorates blood circulation to enrich blood, granulation promoting reunion of fractured tendons and bones medicine, promotes union of fracture, all pains of blood stasis trusted subordinate, the arthralgia pain clonic spasm of the muscle is auxilliary, major-minor phase and, make each component drug effect produce synergism.
The present invention compared with prior art has following advantage: 1, the used medicine of the present invention is a pure natural medical, has promoting blood circulation and stopping pain, and blood stasis removing stimulates the menstrual flow, reunion of fractured tendons and bones, and remarkable efficacy such as expelling pus and promoting granulation cure mainly diseases such as fracture, traumatic injury, various red injury, impairment caused by overstrain; 2, this Chinese medicine does not have special odor, is fit to adult, child administration; 2, curative effect height, relieving pain is especially taken the soonest and was promptly started effect in 40 minutes, and obviously sensation is not bitterly or pain relief; Short treating period, with 30 days be a course of treatment, generally in one, serious symptom is 2～3 courses of treatment; According to the nearly 3 years use treatment statistics to 173 various impairment caused by overstrain patients such as example fracture, traumatic injury, effective percentage reached 100%, and cure rate reaches 98%, and without any side effects, takes the no vomiting and diarrhoea phenomenon in back, and is harmless to liver, brain, the heart, kidney, do not have allergy and reacts.
[usage and dosage]: 1, obey 2～3 every day, each 3～5g, 30 days is a course of treatment; Taking medicine preceding is introduction with Chinese liquor, and the child is cut down according to the circumstance according to the age body weight.
[taboo] avoids pungent food and greasy food.
[specification] every packed 10g.
[storage] sealing.
The specific embodiment
Following examples are in order to further specifying the present invention, but not as limitation of the present invention.
Embodiment 1:
Be used for fracture prescription 1: Olibanum 30g, Myrrha 30g, Flos Carthami 40g, Radix Et Rhizoma Rhei 25g, Radix Dipsaci 30g, Sanguis Draxonis 30g, Pyritum 35g, eupolyphage sece steleophaga 30g, drynaria baronii 45g, Radix Angelicae Sinensis 50g, Crinis Carbonisatus 20g.
Be used for fracture prescription 2: Olibanum 25g, Myrrha 25g, Flos Carthami 40g, Radix Et Rhizoma Rhei 25g, Radix Dipsaci 25g, Sanguis Draxonis 30g, Pyritum 35g, eupolyphage sece steleophaga 25g, drynaria baronii 45g, Radix Angelicae Sinensis 40g, Crinis Carbonisatus 20g.
Embodiment 2:
Be used for the bruise prescription: Olibanum 25g, Myrrha 25g, Flos Carthami 40g, Radix Et Rhizoma Rhei 25g, Radix Dipsaci 30g, Sanguis Draxonis 30g, Pyritum 30g, eupolyphage sece steleophaga 30g, drynaria baronii 35g, Radix Angelicae Sinensis 40g, Crinis Carbonisatus 10g.
Embodiment 3:
Be used for weak impairment caused by overstrain prescription: Olibanum 25g, Myrrha 25g, Flos Carthami 40g, Radix Et Rhizoma Rhei 25g, Radix Dipsaci 25g, Sanguis Draxonis 30g, Pyritum 25g, eupolyphage sece steleophaga 30g, drynaria baronii 35g, Radix Angelicae Sinensis 50g, Crinis Carbonisatus 10g.
Clinical drug of the present invention is selected from example in year October 173 in March, 2006 to 2009, maximum 69 years old age, and minimal ages 8 years old, wherein one-sided limb fracture 42 examples, lumbar vertebra incarceration fracture 3 examples, calcaneus comminuted fracture 17 examples, the fracture of falling is hindered 5 examples; Merge bruise 65 examples, joint dislocation 13 examples, limbs open injury 28 examples.Classification of fracture is pressed the typing standard, the I type: the fissure fracture of phalanges distal joint face, no articular surface displacement; II type: refer to have tangible articular surface fracture displacement, but the fracture pulverizing is not serious; III type: the serious comminuted fracture of the heavy damage of articulations digitorum manus face and distal tibial.I type 33 examples in this case history 95 routine miscellaneous fractures, II type 26 examples, III type 36 examples.
Criterion of therapeutical effect: the healing evaluation to Pilon fracture is divided into: excellent, good, differ from 3 three grades.Excellent: healing fully, 75% ankle motion recovers, normal gait; Very: pain is arranged during walking, but do not hinder one's work and light activity, 50% ankle motion recovers, normal gait; Difference: suffer from limb pain, hinder one's work and walk.The ankle joint motions are less than 50%, and swelling is obvious, and there is the medial and lateral malleolus displacement in visible ankle deformity.
This treatment is taken medicine the oral medicine instructions of taking in observing by all kinds of fracture and bruise: obeys every day three times, and each 3g, 30 days is a course of treatment, is introduction with Chinese liquor when taking medicine.
Retain information 121 example statistics therapeutic outcomes according to following up a case by regular visits to feedback: in 121 examples, effective 121 examples, invalid 0 example, effective percentage 100%; Cure 119 examples, cure rate 98.35%.
Employing clinical comparison statistics, fracture and bruise are used oral medicine 50 examples of the present invention (31 examples of fracturing, bruise 19 examples) and are contrasted with SHENYANG HONGYAO, and statistics shows as a result, uses the effect significant difference in red medicine treatment situation of the present invention and contrast and the complication.
Two groups of curative effect of medication are used comparing result
Claims (3)
1. red injury oral Chinese medicine is characterized in that this Chinese medicine is to be made by following Chinese medicine raw materials by weight proportion:
Olibanum 15～30g Myrrha 15～30g
Flos Carthami 20～40g Radix Et Rhizoma Rhei 10～25g
Radix Dipsaci 15～30g Sanguis Draxonis 15～30g
Pyritum 20～35g eupolyphage sece steleophaga 15～30g
Drynaria baronii 30～45g Radix Angelicae Sinensis 30～50g
Crinis Carbonisatus 10～20g
The carbide that described Crinis Carbonisatus becomes for the between twenty and fifty hair color roasting of not having hair dyed;
Each component of above-mentioned dosage is crushed to 60～80 orders makes powder or other dosage form.
2. according to the described red injury oral Chinese medicine of claim 1, it is characterized in that this Chinese medicine made by following materials of weight proportions component:
Olibanum 25～30g Myrrha 25～30g
Flos Carthami 30～40g Radix Et Rhizoma Rhei 20～25g
Radix Dipsaci 25～30g Sanguis Draxonis 25～30g
Pyritum 25～35g eupolyphage sece steleophaga 25～30g
Drynaria baronii 30～45g Radix Angelicae Sinensis 35～45g
Crinis Carbonisatus 15～20g.
3. according to the described red injury oral Chinese medicine of claim 1, it is characterized in that this Chinese medicine made by following materials of weight proportions component:
Olibanum 30g Myrrha 30g
Flos Carthami 40g Radix Et Rhizoma Rhei 25g
Radix Dipsaci 30g Sanguis Draxonis 30g
Pyritum 35g eupolyphage sece steleophaga 30g
Drynaria baronii 45g Radix Angelicae Sinensis 50g
Crinis Carbonisatus 20g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105318648A CN102000233A (en) | 2010-10-25 | 2010-10-25 | Oral traditional Chinese medicine for knife wounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105318648A CN102000233A (en) | 2010-10-25 | 2010-10-25 | Oral traditional Chinese medicine for knife wounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102000233A true CN102000233A (en) | 2011-04-06 |
Family
ID=43808102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105318648A Pending CN102000233A (en) | 2010-10-25 | 2010-10-25 | Oral traditional Chinese medicine for knife wounds |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102000233A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102793893A (en) * | 2012-08-27 | 2012-11-28 | 刘伟娟 | Preparation method for traditional Chinese medicine lotion for treatment of liver depression fire formation-type closed fracture |
| CN104435571A (en) * | 2014-11-18 | 2015-03-25 | 王献美 | Tendon-relaxing and bone-strengthening capsule |
| CN105434752A (en) * | 2015-12-25 | 2016-03-30 | 陈新宇 | Fracture healing promoting medicinal composition and preparation thereof |
| CN105770615A (en) * | 2014-12-22 | 2016-07-20 | 天津嘉创生物科技有限公司 | Traditional Chinese medicine suspension for treating rear-quarter palsy of dog and preparation method thereof |
| CN107007762A (en) * | 2017-06-16 | 2017-08-04 | 郜金元 | A kind of Chinese medicine composition, its preparation method and application for treating fracture |
| CN111297997A (en) * | 2020-01-16 | 2020-06-19 | 钱茂发 | Oral Chinese medicinal composition for treating bone diseases and preparation method thereof |
| CN116549550A (en) * | 2023-03-01 | 2023-08-08 | 董绍帅 | A kind of traditional Chinese medicine pill for bruises |
-
2010
- 2010-10-25 CN CN2010105318648A patent/CN102000233A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102793893A (en) * | 2012-08-27 | 2012-11-28 | 刘伟娟 | Preparation method for traditional Chinese medicine lotion for treatment of liver depression fire formation-type closed fracture |
| CN104435571A (en) * | 2014-11-18 | 2015-03-25 | 王献美 | Tendon-relaxing and bone-strengthening capsule |
| CN105770615A (en) * | 2014-12-22 | 2016-07-20 | 天津嘉创生物科技有限公司 | Traditional Chinese medicine suspension for treating rear-quarter palsy of dog and preparation method thereof |
| CN105434752A (en) * | 2015-12-25 | 2016-03-30 | 陈新宇 | Fracture healing promoting medicinal composition and preparation thereof |
| CN107007762A (en) * | 2017-06-16 | 2017-08-04 | 郜金元 | A kind of Chinese medicine composition, its preparation method and application for treating fracture |
| CN111297997A (en) * | 2020-01-16 | 2020-06-19 | 钱茂发 | Oral Chinese medicinal composition for treating bone diseases and preparation method thereof |
| CN116549550A (en) * | 2023-03-01 | 2023-08-08 | 董绍帅 | A kind of traditional Chinese medicine pill for bruises |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102000233A (en) | Oral traditional Chinese medicine for knife wounds | |
| CN102327380A (en) | Chinese medicinal composition for treating knee osteoarthritis | |
| CN102908442B (en) | Composition for treating traumatic injuries and medicinal liquor thereof | |
| CN100394955C (en) | Chinese traditional medicine preparation for treating bone fracture and traumatic injury | |
| CN105560662A (en) | External-use traditional Chinese medicine composition for treating knee osteoarthritis | |
| CN101983710B (en) | External application medicine for orthopedics and traumatology, production method and use method thereof | |
| CN103169822B (en) | Synovitis hui-nationality ointment and preparation method thereof | |
| CN102342983B (en) | Chinese medicinal composition for treating pain in the legs and numbness of the extremities and preparation method of preparation thereof | |
| CN106728615A (en) | Chinese medicine composition for synthetism life bone and preparation method thereof | |
| CN103156992A (en) | An external application plaster combination for treatment of fracture injuries and a preparation method thereof | |
| CN101703619A (en) | Chinese medicament for treating hyperosteogeny and osteoarthritis | |
| CN101496838A (en) | Chinese medicament preparation for treating hyperosteogeny and rheumatism and preparation method thereof | |
| CN100534480C (en) | Bone-setting medicine and preparation method thereof | |
| CN103550443B (en) | The externally applied formulation for the treatment of meniscal sports injury and preparation method | |
| CN103127353A (en) | Pharmaceutical composition for treating rheumatoid arthritis | |
| CN101194985B (en) | Orally taken Chinese medicine composition for treating articulatio genus hyperosteogeny | |
| CN104857463A (en) | Traditional Chinese medicine combination for curing metrorrhagia and metrostaxis | |
| CN103191305A (en) | Traditional Chinese medicine composition for treating hyperosteogeny | |
| CN104027451B (en) | A kind of Chinese medicine for the treatment of deficiency of the liver and kindey pattern of syndrome sciatica | |
| CN1246022C (en) | Fracture setting pellet | |
| CN102091204B (en) | Traditional Chinese medicine composition for treating traumatic injury and deep phlebitis and preparation method and application thereof | |
| CN102526365B (en) | Bonesetting capsules for treating traumatic injury | |
| CN103432509B (en) | The topical agent for the treatment of prolapse of lumbar intervertebral disc | |
| CN101904922B (en) | Plaster for treating pain caused by femoral head necrosis | |
| CN104096177A (en) | Medicine for treating painful physique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20110406 |